Abrahami Avishai sold $578K of MNDY

Abrahami Avishai sold 7,500 shares of monday.com Ltd. (MNDY) at an average of $77.02 ($76.12–$77.72, $0.58M total) across 3 trades on 2026-11-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Abrahami Avishai
Published Nov 16, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MNDY
Neutral
medium confidence
Mentioned
$MNDY
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MNDYNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity, but it does not include any new operational, financial, or regulatory information about monday.com.

02

Market read

For traders, this is mainly a sentiment/positioning input rather than a fundamental catalyst.

03

What to watch

The article does not state whether other insiders sold/bought around the same time, nor does it provide context on total insider ownership changes beyond the post-transaction share count.

Relevance 4/10Novelty 5/10Timing: SEC Form 4 filed 2026-11-16, covering sales dated 2026-11-12.

Background

The article summarizes an SEC Form 4 insider transaction by monday.com director Abrahami Avishai, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$MNDYNeutralMedium confidence
Context

Director Abrahami Avishai sold about 7,500 shares of monday.com on a 10b5-1 plan, totaling $577,648, per SEC Form 4.

Expected impact

Likely limited impact, with any short-term pressure fading as the market treats the sale as routine 10b5-1 execution.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but the transaction is explicitly under a pre-arranged 10b5-1 plan and the article provides no accompanying fundamental change.

Market effects

Minimal, as this is company-specific insider execution with no sector-wide regulatory or operational change.

None indicated.

None indicated.

Counterpoint

Traders could view the sale as a signal of reduced confidence, especially if the 10b5-1 plan timing coincides with other negative company-specific developments not mentioned here.

Key entities

  • monday.com Ltd.

    US-listed company whose director insider sale is disclosed on SEC Form 4.

  • Abrahami Avishai

    Director of monday.com who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MNDYHigh

Jefferies cuts monday.com stock price target on headwinds

Jefferies reduced its price target for monday.com (MNDY) to $90 from $95, citing operational challenges and slower growth. The company's Q4 revenue guidance missed estimates, though it reported a Q3 earnings beat. MNDY's stock is down 52% year-to-date, trading at $79.93 with a market cap of $3.38 billion. Analysts remain cautious about growth sustainability despite strong gross margins and revenue growth.

$CEGHighAI 8/10

Constellation, NRG Jump; monday.com, CKX, QXO Move Big

Constellation Energy reported Q3 2026 earnings of $5.06 per share, beating estimates, and raised full-year guidance to $12.50-$12.80 per share. Shares rose 8.52%. monday.com's revenue grew 19% YoY, but shares fell 6.80% due to lower Q4 guidance. KKR reported record Q3 profit and plans $40B in investor returns, shares up 2.62%. NRG Energy's Q3 earnings beat estimates, shares jumped 9.53% after announcing a $4B asset sale and increased buybacks.